Dr. Daniel Q. Huang graduated from the Yong Loo Lin School of Medicine, National University of Singapore. He leads hepatocellular carcinoma research in the Division of Gastroenterology and is also proficient in diagnostic and therapeutic endoscopy.
Dr. Huang’s research interest is in the early detection and prevention of hepatocellular carcinoma in non-alcoholic fatty liver disease and viral hepatitis. Dr. Huang is working on non-invasive strategies to risk stratify and assess treatment response in NASH and hepatocellular carcinoma by leveraging advanced imaging-, genomic-, and RNA-based approaches. Dr. Huang also has an interest in hepatitis B and has led several studies on the indeterminate phase, contributing to an expansion of the treatment indications for chronic hepatitis B in the latest World Health Organization guidelines (2024) to include the indeterminate phase. Dr. Huang has co-authored clinical practice guidelines on behalf of the American Gastroenterology Association and is contributing to several guidance statements of the Asia Pacific Association for the Study of the Liver (APASL).
Dr. Huang has published more than 200 peer-reviewed articles, with first or corresponding authorship in journals such as Cell Metabolism, Gastroenterology, Hepatology, Nature Reviews Disease Primers, Gut, the Lancet Gastroenterology and Hepatology, and the Lancet Oncology. He has received awards for his research from the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). Dr. Huang is a frequent invited speaker at international scientific meetings, such as the AASLD, the American Association for Cancer Research (AACR), the APASL, and in multiple regional meetings in Asia. His research is funded by several grants, including the transition award from the National Medical Research Council. He currently serves as the Hepatology chair of the Emerging Leaders Committee (Asia Pacific Gastroenterology Association) and as an Associate Editor of Alimentary Pharmacology and Therapeutics.
Area of Interest:
